Wegovy Pill Just Changed: Why Lilly Stock Could Still Win
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Knowing what data is needed for financial analysis is crucial for accurate assessments. Gather the essential information to make informed financial decisions.
26,603 articlesA new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
The Shiba Inu project is under pressure after its official social channel sparked backlash with a controversial poll ...
As buyers face higher rates and lean inventories, mixed-density housing keeps expanding, offering entry points within...
Kiavi announced a $350 million rated securitization of residential transition loans, marking its sixth rated deal and...
AI fears roiled tech names, dragging CrowdStrike lower despite strong fundamentals. Analysts see a 40% upside as sent...
A wave of new analyst calls on Thursday centers on Alcon, First Solar, Five Below, Joby Aviation, Spotify, Trade Desk...
U.S. stocks paused as energy costs rose and Middle East tensions persisted. Citi cautions that iran conflicts just ad...
Pi Network bulls defended recent gains as traders eye a potential breakout this week. The latest network (pi) price p...
Rocket Lab’s stock faced a sharp pullback before rebounding in March. This article breaks down what caused the drop, ...
Oil prices plummet after a Reuters-style rumor that the G7 may tap 400 million barrels from strategic reserves. Crypt...
Micron Technology led a Tuesday rally in the memory sector, with peers posting solid gains as a new AMAT collaboratio...
Markets lean on Treasurys as the only credible anchor amid volatility. Analysts say the U.S. debt market remains the ...